Clinical Trial: SKB103 for Injection in Advanced Solid Tumors

U.S., March 11 -- ClinicalTrials.gov registry received information related to the study (NCT07459998) titled 'SKB103 for Injection in Advanced Solid Tumors' on March 04.

Brief Summary: This is a phase 1/2 clinical study to evaluate the safety and efficacy of SKB103 in participants with advanced solid tumors. The study includes a dose escalation stage, a dose expansion stage, and a indication expansion stage.

Study Start Date: April 30

Study Type: INTERVENTIONAL

Condition: Advanced Solid Tumors

Intervention: DRUG: SKB103 for injection monotherapy

IV infusion on Day 1 of each cycle, every 3 weeks (Q3W), until radiographic disease progression (PD), intolerable toxicity, participant request for discontinuation, lost to follow-up, or dea...